From 1st October 2015 COS has raised EUR 10 million through the sale of Series A Preferred Stock to the American private equity firm, Signet Healthcare Partners.
The Company intends to use these proceeds to increase its plant capacity and fund the development of hard-to-produce generic APIs. The partnership is expected to result in a significant increase of the Company’s activities in the API market.
Founded in 1998, Signet Healthcare Partners provides growth capital to commercial-stage healthcare companies around the world. Over the past 16 years, Signet has organized three funds and completed investments in 44 companies with 26 exits. The team, comprised of five professionals with principal offices in New York City, brings over 100 years of collective healthcare experience in the specialty pharmaceutical, medical device, private equity and investment banking businesses. For more information, please visit Signet online at www.signethealthcarepartners.com